HomeNewsBusinessEconomyCoronavirus pandemic| Amidst remote working, technology poses unusual challenges

Coronavirus pandemic| Amidst remote working, technology poses unusual challenges

On one hand while there are privacy concerns, on the other professionals not used to video calls and meetings are making hilarious mistakes.

April 04, 2020 / 10:35 IST
Story continues below Advertisement
Representative image
Representative image

Suresh Prakasam had never before participated in a video meeting during his 30-year career as a marketing executive. So amidst the coronavirus (COVID-19) lockdown, when he was required to do client meetings over video, little did he know that his work laptop had an auto camera mode for e-meetings. He turned up shirtless for one such discussion and has since not been able to face clients.

COVID-19 has led to companies mandating remote working for employees. However, to ensure business continuity all physical meetings, conferences and daily briefings are now being converted into electronic ones. But this is not devoid of its unique challenges.

Story continues below Advertisement

Follow our LIVE Updates on the coronavirus pandemic here

On April 2, miscreants hacked into industry body Broadcast Audience Research Council (BARC)'s second post-COVID-19 viewership insights conference hosted via popular video conferencing app ZOOM.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show